These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2011099)

  • 1. Differentiating agents in malignant disease.
    Bruetman DG; Harris JE; Anderson KM
    Med Pediatr Oncol; 1991; 19(2):71-83. PubMed ID: 2011099
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of differentiation therapy].
    Hozumi M
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1006-8. PubMed ID: 8512331
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of cyto-differentiating agents in oncology].
    Gadzhieva SSh; Polosukhina ER; Nikolaeva TG; Treshchalina EM; Baryshnikov AIu; Nebol'sin VE; Antonov VG
    Vopr Onkol; 2006; 52(3):267-74. PubMed ID: 17191698
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of cellular differentiation and cell fate for cancer therapy.
    Moutouh-de Parseval LA; Chan KW
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1268-73. PubMed ID: 15648947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytodifferentiation: a novel approach to cancer treatment and prevention.
    Garattini E; Terao M
    Curr Opin Pharmacol; 2001 Aug; 1(4):358-63. PubMed ID: 11710733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation therapy for solid tumors.
    Xu WP; Zhang X; Xie WF
    J Dig Dis; 2014 Apr; 15(4):159-65. PubMed ID: 24373518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atiprimod: a multi-functional drug candidate for myeloid and other malignancies.
    Shailubhai K
    Leuk Res; 2007 Jan; 31(1):9-10. PubMed ID: 16860863
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review.
    Biedler JL; Spengler BA; Ross RA
    Prog Clin Biol Res; 1990; 354A():287-312. PubMed ID: 2247493
    [No Abstract]   [Full Text] [Related]  

  • 9. New targets for cancer chemotherapy.
    Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
    Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of cancer.
    Lancet; 1983 Apr; 1(8328):799-800. PubMed ID: 6132134
    [No Abstract]   [Full Text] [Related]  

  • 11. [The oncobiogram-- an indicator of chemotherapy in solid malignant human tumors].
    Schönfelder M
    Zentralbl Chir; 1974 Sep; 99(38):1198-208. PubMed ID: 4454780
    [No Abstract]   [Full Text] [Related]  

  • 12. Induced cell differentiation in cancer therapy.
    Bloch A
    Cancer Treat Rep; 1984 Jan; 68(1):199-205. PubMed ID: 6692427
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use of differentiating agents in cancer therapy.
    Dmitrovsky E; Markman M; Marks PA
    Cancer Chemother Biol Response Modif; 1990; 11():303-20. PubMed ID: 2223397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fighting Resilient Cancers with Iron.
    Chen JJ; Galluzzi L
    Trends Cell Biol; 2018 Feb; 28(2):77-78. PubMed ID: 29223642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.
    Miller WH
    Cancer; 1998 Oct; 83(8):1471-82. PubMed ID: 9781940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Physical and chemical agents inducing cell death and differentiation.
    Di Pietro R
    Curr Pharm Des; 2010; 16(12):1356-7. PubMed ID: 20298162
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation-inducing therapy for solid tumors.
    Kawamata H; Tachibana M; Fujimori T; Imai Y
    Curr Pharm Des; 2006; 12(3):379-85. PubMed ID: 16454751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in tumor suppression.
    Sassano A; Platanias LC
    Cancer Lett; 2008 Feb; 260(1-2):11-9. PubMed ID: 18180097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer.
    Botrugno OA; Santoro F; Minucci S
    Cancer Lett; 2009 Aug; 280(2):134-44. PubMed ID: 19345000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to cancer therapy. The First International Symposium of Hiroshima Cancer Seminar, Hiroshima, November 1990.
    Tahara E
    J Cancer Res Clin Oncol; 1991; 117(3):269-72. PubMed ID: 1674513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.